- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Fischer Medical Ventures' board has approved the financial results for the quarter ended June 30, 2025. The company reported consolidated revenue from operations of Rs 4.54 Cr and a net loss of Rs 0.61 Cr for the quarter. The 32nd Annual General Meeting will be held on September 29, 2025, via video conferencing. The board also approved the appointment of M/s Nuren Lodaya & Associates as Scrutinizer for the AGM and put forward their appointment as Secretarial Auditors for five years. Additionally, Dr. Jacob Thomas, an Independent Director, has resigned due to personal reasons. Share transfer books will be closed from September 23 to September 29, 2025.